Harpoon Therapeutics Remains Volatile After Promising News

MarketBeat.com – MarketBeat

Biotech stocks are often among the market’s most volatile, and Harpoon Therapeutics Inc. (NASDAQ: HARP) offers a perfect example of that.

The stock rocketed to an eight-month high Monday, advancing as much as 191% intraday before settling down to a gain of 22.61%. Shares closed at $1.41 Monday, up $0.26. Tuesday, the stock closed lower after gapping down at the open. 

Monday’s huge upside action followed the company’s release of updated interim results for its myeloma drug that’s in Phase 1 clinical trials. The treatment is currently known as HPN217.

According to Harpoon’s news release, “The interim results, as of the data cut-off

→ Continue reading at Entrepreneur

More from author

Related posts


Latest posts

The Grim Origins of an Ominous Methane Surge

That is, as we polluted less—heavy industry spun down, flights got canceled, people stopped commuting—we also produced less of the pollutant that normally breaks...

Antihelium Offers Hope in the Search for Dark Matter

In 2010, physicists at the Large Hadron Collider began producing an exotic form of antimatter known as antihelium. Antimatter is that elusive substance that annihilates upon...

A Smart Way to Get Ahead of the Next Flu Surge

Singh says a smart thermometer reading is particularly useful for people who have only mild symptoms and can be spared a visit to the...